Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company UpdateBusiness Wire • 01/10/22
Novocure Signs Agreement to Acquire and Construct Building in Downtown Portsmouth, New HampshireBusiness Wire • 12/07/21
Novocure Announces 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research ProgramBusiness Wire • 12/06/21
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-small Cell Lung CancerBusiness Wire • 11/22/21
2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed GlioblastomaBusiness Wire • 11/15/21
Novocure Announces 31 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2021 Annual MeetingBusiness Wire • 11/15/21
NovoCure Limited (NVCR) CEO Asaf Danziger on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/28/21
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal INNOVATE-3 Trial of Tumor Treating Fields in Ovarian CancerBusiness Wire • 10/28/21
Novocure Reports Third Quarter 2021 Financial Results and Provides Company UpdateBusiness Wire • 10/28/21
Novocure Announces 15 Presentations at the American Society for Radiation Oncology 2021 Annual MeetingBusiness Wire • 10/21/21